IOMERVU Trademark

Trademark Overview


On Thursday, July 11, 2024, a trademark application was filed for IOMERVU with the United States Patent and Trademark Office. The USPTO has given the IOMERVU trademark a serial number of 79404602. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, September 19, 2024. This trademark is owned by Bracco Suisse SA,. The IOMERVU trademark is filed in the Pharmaceutical Products category with the following description:

Contrast media for in-vivo imaging.
iomervu

General Information


Serial Number79404602
Word MarkIOMERVU
Filing DateThursday, July 11, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, September 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesContrast media for in-vivo imaging.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 19, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBracco Suisse SA,
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Thursday, September 19, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, September 19, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 19, 2024APPLICATION FILING RECEIPT MAILED
Friday, November 1, 2024NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords


iomervu imaging vivo media contrast